Correction to: Andexanet Alfa: First Global Approval

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-1950

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Correction to: Andexanet Alfa: First Global Approval ; day:21 ; month:7 ; year:2018 ; pages:1
Drugs ; (21.7.2018), 1

Creator: Heo, Young-A

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40265-018-0954-y

URN: urn:nbn:de:101:1-2018082212242596688607

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Heo, Young-A
SpringerLink (Online service)

Other Objects (12)

Andexanet Alfa: First Global Approval

Correction to: Efanesoctocog Alfa: First Approval

Efanesoctocog Alfa: First Approval

Correction to: Elagolix: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Revefenacin: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Andexanet Alfa: First Global Approval

Correction to: Efanesoctocog Alfa: First Approval

Efanesoctocog Alfa: First Approval

Correction to: Elagolix: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Revefenacin: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Andexanet Alfa: First Global Approval

Correction to: Efanesoctocog Alfa: First Approval

Efanesoctocog Alfa: First Approval

Correction to: Elagolix: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Revefenacin: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: Andexanet Alfa: First Global Approval

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Andexanet Alfa: First Global Approval

Correction to: Efanesoctocog Alfa: First Approval

Efanesoctocog Alfa: First Approval

Correction to: Elagolix: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Revefenacin: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Andexanet Alfa: First Global Approval

Correction to: Efanesoctocog Alfa: First Approval

Efanesoctocog Alfa: First Approval

Correction to: Elagolix: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Revefenacin: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Andexanet Alfa: First Global Approval

Correction to: Efanesoctocog Alfa: First Approval

Efanesoctocog Alfa: First Approval

Correction to: Elagolix: First Global Approval

Correction to: Fremanezumab: First Global Approval

Correction to: Ivosidenib: First Global Approval

Correction to: Sarecycline: First Global Approval

Correction to: Revefenacin: First Global Approval

Correction to: Caplacizumab: First Global Approval

Correction to: Delafloxacin: First Global Approval

Correction to: Ibalizumab: First Global Approval

Correction to: Moxetumomab Pasudotox: First Global Approval

Related objects

Reset password